Double-layer biodegradable temporising matrix reconstruction for abdominal skin and soft-tissue reconstruction

  1. Rushabh Shah 1,
  2. Ailbhe Kiely 2 and
  3. Stuart McKirdy 2
  1. 1 Department of Burns and Plastic Surgery, Manchester University NHS Foundation Trust, Manchester, UK
  2. 2 Department of Plastic and Reconstructive Surgery, Royal Preston Hospital, Preston, UK
  1. Correspondence to Rushabh Shah; tunnellordator@gmail.com

Publication history

Accepted:30 Oct 2022
First published:11 Nov 2022
Online issue publication:11 Nov 2022

Case reports

Case reports are not necessarily evidence-based in the same way that the other content on BMJ Best Practice is. They should not be relied on to guide clinical practice. Please check the date of publication.

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a rare, locally invasive dermal sarcoma. The management is generally surgical, with wide local excision (WLE) forming the mainstay of treatment. Large abdominal wall defects are most aesthetically reconstructed using pedicled or free flaps; however, these require tumour-free surgical margins, and are off-set by donor site morbidity. We describe an alternative, aesthetic and low-morbidity technique for reconstruction of a subfascial defect following WLE of DFSP in a young woman in her early 20s, using two layers of a novel synthetic dermal matrix (NovoSorbBTM). To our knowledge, a double-layer reconstruction using an artificial dermal matrix has never been described for trunk reconstruction. We found that double-layer biodegradable temporising matrix can restore the inherent thickness and pliability of skin in a partial-thickness abdominal wall defect and offers improved durability and cosmesis compared with skin grafting or indeed single layer skin substitutes alone.

Background

Dermatofibrosarcoma protuberans (DFSP) is a rare slow growing and locally aggressive sarcoma of dermal origin.1 It accounts for 1% of soft-tissue sarcomas, and has an incidence of around 1–5 cases per million population per year.2 They are most commonly found over the trunk, and can present as skin-coloured, non-tender cutaneous plaques, which over time become nodular, hard and protuberant.3 Although these tumours rarely metastasise, they are highly locally invasive and easily recurring.4 Surgical management with either wide local excision (WLE) with 1–5 cm margins, or Mohs micrographic surgery (MMS), forms the mainstay of treatment.5 Radiotherapy may be offered as adjuvant treatment when resection margins are positive or whenever conservative surgical management is required.6

Partial-thickness abdominal wall defects involve the loss of skin and subcutaneous tissues but retain an adequate musculofascial domain.7 Pedicled or free tissue transfer can provide adequate soft-tissue coverage for large abdominal wall defects; however, the necessity for tumour-free surgical margins precludes its immediate use.7 These would also ideally be tissue expanded ahead of reconstruction, which has oncological considerations if margins are not clear.

While skin grafts are a reasonable reconstructive option, they do not offer the durability or cosmesis of a flap reconstruction. Skin grafts, particularly on the abdominal wall, have a predilection for plaque-like scarring and significant contraction and hypertrophy.8 These are often difficult to manage in the long-term postoperative period, aside from the cosmetic consequences of this in a prominent area of the body.

As an alternative, artificial dermal templates have been utilised to create a suitable wound bed for grafting, with the aim to recreate the inherent thickness and pliability of skin.9 NovoSorb biodegradable temporising matrix (BTM) is a 2 mm thick, synthetic dermal matrix used for complex wound reconstruction. It typically involves a two-stage procedure: implantation of the bilaminar matrix allowing for host integration and creation of neodermis; and subsequent delamination of the superficial membrane and application of split thickness skin graft over the vascularised matrix. BTM has been shown to be a safe and reliable reconstructive option in complex wounds including acute burns, necrotising fasciitis and free flap donor site reconstruction.10

We describe an alternative, aesthetic and low-morbidity technique to reconstructing a large, partial thickness abdominal wall defect following WLE of DFSP, using two layers of a novel synthetic dermal matrix (NovoSorb BTM), to achieve an improved contour in a patient with a step defect of approximately 3 cm. We demonstrate that abdominal wall reconstruction using double-layer BTM can better mimic the thickness and pliability of skin and subcutaneous tissues, and offers improved durability and cosmesis compared with skin grafting or indeed single layer skin substitutes alone, without the significant challenges and risks posed by flap reconstruction. To our knowledge, a double-layer BTM has never been described for abdominal wall reconstruction.

Case presentation

A young woman in her early 20s, with no significant medical history, was referred to our outpatient clinic with a large, firm mass over the right flank. The patient reported that the mass had grown considerably in the preceding 2 months and become tender and firm. On examination, there was a 5×6 cm firm, tender lesion over the right anterolateral abdomen, underlying a congenital naevus. There was no palpable cervical, axillary or inguinal lymphadenopathy.

Investigations

The patient underwent an ultrasound scan demonstrating a 4×4×3 cm well defined, mixed solid cystic mass located in the subcutaneous tissues. Non-contrast MRI of the abdomen was subsequently performed, showing a 4.8×3.8×4.8 cm soft-tissue lesion with peripheral enhancement in the right anterolateral abdominal wall, abutting and distorting the underlying musculature with no frank infiltration. An ultrasound-guided core biopsy was performed, and histological analysis confirmed DFSP with high-grade features. There was no evidence of metastasis on CT chest, abdomen and pelvis.

Treatment

After discussion at the regional sarcoma multidisciplinary team meeting, the patient underwent a WLE of the tumour with 3 cm peripheral margins. The tumour was excised en bloc down to muscle, resulting in a large 10×14 cm subfascial defect. After careful haemostasis and saline irrigation, a 2 mm layer of BTM was cut to shape and applied to the defect. The BTM was secured using simple interrupted 4–0 prolene sutures with careful quilting and dressed with foam and Hypafix (BSN Medical, Hamburg, Germany). The patient was discharged the same day. Histopathological examination of the specimen demonstrated a well differentiated, 6×8 cm dermatofibrosarcoma with clear peripheral and deep margins. There were no plans for postoperative radiotherapy.

The patient returned to our dressing clinic on a weekly basis for dressing changes. At 2 weeks, the BTM had completely adhered to the wound and demonstrated signs of integration (see figure 1). By 6 weeks, the BTM was salmon pink in colour, with capillary refill demonstrable through the seal, suggesting that the wound bed was ready for grafting. A second layer of BTM was planned to be applied to improve the significant contour deformity of the tumour bed. As a day-case procedure under local anaesthesia, the BTM was delaminated, the surface refreshed by dermabrasion and a second layer of BTM applied to the wound and secured using 5–0 prolene simple interrupted sutures (see figure 2).

Figure 1

Week 2 following first layer of BTM. Note that BTM has completely adhered to the wound and demonstrating signs of integration. BTM, biodegradable temporising matrix.

Figure 2

The image on the left is taken 6 weeks after BTM application and subsequent delamination, demonstrating a well-vascularised tumour bed with significant contour deformity. The image on the right is after the application of second layer of BTM. BTM, biodegradable temporising matrix.

After complete integration by 7 weeks, the patient underwent application of split thickness skin graft to the wound, under a general anaesthetic as a day-case procedure (see figure 3). The graft was harvested from the right thigh, inset using 4–0 vicryl rapide (Ethicon) and skin glue, and dressed with Jelonet, gauze and Hypafix.

Figure 3

Intraoperative photo of wound bed after delamination of second layer BTM. BTM, biodegradable temporising matrix.

Outcome and follow-up

At 14 days postoperatively, the skin graft had fully taken, and donor site healed (see figure 4). By 14 weeks, the scar had started to mature with no obvious contour defect or contracture, and no evidence of local and regional tumour recurrence (see figure 5). Overall, the contour was improved compared with grafting alone or single layer ADM, and the skin pliability was notably good.

Figure 4

1 week after application of split-thickness skin graft.

Figure 5

Fourteen weeks after application of split-thickness skin graft.

Discussion

Surgical excision with disease-free margins is the cornerstone of treatment for primary DFSP. Conventional management is with WLE of the tumour with 1–5 cm of uninvolved skin and subcutaneous tissue, at least down to underlying deep fascia. Recurrence rates following WLE have been reported between 0% and 60%.11–13 Alternatively, MMS can limit the excision to histologically involved tissue, and has been reported to achieve recurrence rates between 0% and 8.3%.11 13 However, MMS may not be readily available (as was the case in our unit), and recurrence rates post excision are highly user dependent.

Large partial-thickness abdominal wall defects can be reconstructed using several techniques including split-thickness skin grafts, local, pedicled or free flaps. Skin grafts are a valuable option in patients who are unsuitable for complex reconstruction, but pose issues with contour deformity and scar contracture, resulting in poor functional and aesthetic outcomes. Flap reconstruction provides more robust soft-tissue coverage as it protects any exposed anatomical structures and does not undergo retraction. For this patient, there were no obvious local or pedicled options that would provide an aesthetic contour on the patient’s flank, and she would likely have required pre-operative tissue expansion which could have had oncological implications. Free tissue transfer is a useful technique, but not in this case as there were no reasonable options for reconstruction that would justify the significant donor site morbidity such that the contour would not require secondary revisions. What’s more, free tissue transfer has drawbacks due to expense, lengthier operation times and a longer postoperative recovery.13 Finally, when MMS is not available (as in our unit), and subsequent histological evaluation reveals that resection is not tumour free, flap reconstruction can result in a very difficult secondary surgery.13

Artificial dermal templates may be used as an alternative reconstructive option in the surgical management of DFSP, and proved an appropriate, safe and aesthetic option in this patient. The use of a dermal matrix, and in particular, the use of a double layer to better mimic the thickness of the surrounding skin, offered a significant difference in pliability and in the prevention of contraction to what the projected outcome with grafting alone would be. A recent series of 26 cases of BTM use reported a contracture rate of 0.5%–6.4%.14 Dermal substitutes such as Integra and Pelnac have been used previously to reconstruct post-DFSP excision defects of the head and neck and lumbar regions, respectively.15 16 The disadvantage of classic acellular dermal matrices (ADMs) is that they are made of organic material and must be removed if infected if a haematoma collects or if tumour margins are not clear. BTM boasts a distinct advantage in this domain—as an entirely synthetic construct, it can be lifted and a haematoma, collection or infection can be washed out and the matrix replaced. The same can be said for oncological considerations—allowing for re-excision of margins and replacement. BTM as it stands is much less expensive than other ADMs, but in this capacity of being able to be replaced in the above contexts it boasts even further cost savings.17 To our knowledge, there have been no published reports on the use of a double layer of BTM for abdominal wall reconstruction following DFSP excision, and this is its first use in this context.

In our young patient, the initial DFSP resection resulted in a large contour defect with a significant 3 cm step deformity in an aesthetically sensitive region. It is likely that even with a flap reconstruction, secondary debulking procedures such as liposuction and direct excision, would have been required to flatten the bulk of the tissue.18 The use of a double layer of BTM created a smooth, even contour following the primary operation, with the additional vital advantage of allowing for margin control following resection.

Numerous studies have demonstrated the many advantages of BTM reconstruction including short operating time and postoperative recovery period; minimal donor site morbidity; superior resistance to infection compared with biological dermal templates; improved contour defect compared with free flap coverage; reduced scar contracture and improved skin texture compared with skin grafting alone.18–20 Furthermore, in cases such as ours, BTM can act as a temporising measure while the tumour specimen is sent for histopathological analysis, without donor site morbidity or hindrance to secondary excision in case of involved margins.

These authors feel that the advantages to the use of BTM for this patient were numerous; namely—the lack of a major donor site, improved contour, pliability and reduced contraction compared with skin grafting; the oncological safety of being able to remove it and then replace the same sheet to allow for further excision or postoperative complications such as haematoma or infection; as well as the reduced operating time and morbidity compared with pedicled or free flaps. In addition, if there is a residual contour defect, the ADM provides a layer for which to perform fat injection if required in the future, which is not possible in cases where SSG alone has been used. The disadvantages are that it does still require a skin graft, so the patient is not completely free of a donor site; and there is still a degree of contraction—although better than with grafting alone.

Patient’s perspective

‘I am so glad that I went ahead with the double BTM. I feel that it has been extremely beneficial and has made the appearance of the scar so much better than what it would’ve been without. The staff involved were very reassuring and kept me informed at each stage of the process.’

Learning points

  • In the absence of intraoperative frozen sections or Mohs micrographic surgery to confirm tumour-free surgical margins, biodegradable temporising matrix (BTM) can provide a valuable reconstructive option for abdominal wall defects.

  • The use of two layers of BTM can help recreate the thick dermis in young patients and eliminate any resultant contour defect compared with skin grafting or single layer skin substitutes alone, providing excellent functional and aesthetic outcomes.

  • BTM is a cheaper and relatively infection-resistant alternative to other dermal templates (such as integra).

  • Although BTM requires a multistage operation, this cost is potentially offset by the benefits of shorter operating time and postoperative recovery compared with pedicled or free flap reconstruction.

  • For future cases, these authors would consider three-layer BTM to further improve the step defect.

Ethics statements

Patient consent for publication

Acknowledgments

Not applicable.

Footnotes

  • Contributors RS contributed in conception, design and drafting of the article. AK contributed in drafting of the article and participated in patient’s care. SM was the consultant responsible of the patient’s care, and made corrections and revisions to the article.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

References

Use of this content is subject to our disclaimer